Woods, Beth S. orcid.org/0000-0002-7669-9415, Sideris, Eleftherios, Sydes, Matthew R. et al. (41 more authors) (2018) Addition of Docetaxel to First-line Long-term Hormone Therapy in Prostate Cancer (STAMPEDE) : Modelling to Estimate Long-term Survival, Quality-adjusted Survival, and Cost-effectiveness. European Urology Oncology. ISSN 2588-9311
Metadata
Authors/Creators: |
|
---|---|
Copyright, Publisher and Additional Information: | © 2018 The Authors |
Keywords: | Cost-effectiveness analysis, Docetaxel, Prostate cancer |
Dates: |
|
Institution: | The University of York |
Academic Units: | The University of York > Faculty of Social Sciences (York) > Centre for Health Economics (York) |
Depositing User: | Pure (York) |
Date Deposited: | 27 Sep 2018 15:40 |
Last Modified: | 04 Feb 2024 00:56 |
Published Version: | https://doi.org/10.1016/j.euo.2018.06.004 |
Status: | Published online |
Refereed: | Yes |
Identification Number: | https://doi.org/10.1016/j.euo.2018.06.004 |
Related URLs: |